Your browser doesn't support javascript.
loading
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects.
Schwartz, Jules I; Dallob, Aimee L; Larson, Patrick J; Laterza, Omar F; Miller, Jutta; Royalty, Jane; Snyder, Karen M; Chappell, Derek L; Hilliard, Deborah A; Flynn, Mary E; Cavanaugh, Paul F; Wagner, John A.
Affiliation
  • Schwartz JI; Merck Research Laboratories, 126 East Lincoln Avenue, RY34-A500 (A5035), Rahway, NJ 07065, USA. jules_schwartz@merck.com
J Clin Pharmacol ; 48(6): 745-54, 2008 Jun.
Article in En | MEDLINE | ID: mdl-18434566

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Cyclooxygenase Inhibitors / Cyclooxygenase 1 / Cyclooxygenase 2 Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2008 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Cyclooxygenase Inhibitors / Cyclooxygenase 1 / Cyclooxygenase 2 Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2008 Document type: Article Affiliation country: United States Country of publication: United kingdom